Literature DB >> 24892810

Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals.

Lela Kardava, Susan Moir, Naisha Shah, Wei Wang, Richard Wilson, Clarisa M Buckner, Brian H Santich, Leo J Y Kim, Emily E Spurlin, Amy K Nelson, Adam K Wheatley, Christopher J Harvey, Adrian B McDermott, Kai W Wucherpfennig, Tae-Wook Chun, John S Tsang, Yuxing Li, Anthony S Fauci.   

Abstract

Recently, several neutralizing anti-HIV antibodies have been isolated from memory B cells of HIV-infected individuals. Despite extensive evidence of B cell dysfunction in HIV disease, little is known about the cells from which these rare HIV-specific antibodies originate. Accordingly, we used HIV envelope gp140 and CD4 or coreceptor (CoR) binding site (bs) mutant probes to evaluate HIV-specific responses in peripheral blood B cells of HIV-infected individuals at various stages of infection. In contrast to non-HIV responses, HIV-specific responses against gp140 were enriched within abnormal B cells, namely activated and exhausted memory subsets, which are largely absent in the blood of uninfected individuals. Responses against the CoRbs, which is a poorly neutralizing epitope, arose early, whereas those against the well-characterized neutralizing epitope CD4bs were delayed and infrequent. Enrichment of the HIV-specific response within resting memory B cells, the predominant subset in uninfected individuals, did occur in certain infected individuals who maintained low levels of plasma viremia and immune activation with or without antiretroviral therapy. The distribution of HIV-specific responses among memory B cell subsets was corroborated by transcriptional analyses. Taken together, our findings provide valuable insight into virus-specific B cell responses in HIV infection and demonstrate that memory B cell abnormalities may contribute to the ineffectiveness of the antibody response in infected individuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24892810      PMCID: PMC4071400          DOI: 10.1172/JCI74351

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

Review 2.  Confounding B-cell defences: lessons from a staphylococcal superantigen.

Authors:  Gregg J Silverman; Carl S Goodyear
Journal:  Nat Rev Immunol       Date:  2006-06       Impact factor: 53.106

Review 3.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

4.  Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.

Authors:  Bettina Franz; Kenneth F May; Glenn Dranoff; Kai Wucherpfennig
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

5.  High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.

Authors:  Christopher Sundling; Yuxing Li; Nick Huynh; Christian Poulsen; Richard Wilson; Sijy O'Dell; Yu Feng; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

6.  Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.

Authors:  Aran F Labrijn; Pascal Poignard; Aarti Raja; Michael B Zwick; Karla Delgado; Michael Franti; James Binley; Veronique Vivona; Christoph Grundner; Chih-Chin Huang; Miro Venturi; Christos J Petropoulos; Terri Wrin; Dimiter S Dimitrov; James Robinson; Peter D Kwong; Richard T Wyatt; Joseph Sodroski; Dennis R Burton
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers.

Authors:  Weizao Chen; Zhongyu Zhu; Yang Feng; Dimiter S Dimitrov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

8.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

Review 9.  A Blueprint for HIV Vaccine Discovery.

Authors:  Dennis R Burton; Rafi Ahmed; Dan H Barouch; Salvatore T Butera; Shane Crotty; Adam Godzik; Daniel E Kaufmann; M Juliana McElrath; Michel C Nussenzweig; Bali Pulendran; Chris N Scanlan; William R Schief; Guido Silvestri; Hendrik Streeck; Bruce D Walker; Laura M Walker; Andrew B Ward; Ian A Wilson; Richard Wyatt
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

10.  The development of CD4 binding site antibodies during HIV-1 infection.

Authors:  Rebecca M Lynch; Lillian Tran; Mark K Louder; Stephen D Schmidt; Myron Cohen; Rebecca Dersimonian; Zelda Euler; Elin S Gray; Salim Abdool Karim; Jennifer Kirchherr; David C Montefiori; Sengeziwe Sibeko; Kelly Soderberg; Georgia Tomaras; Zhi-Yong Yang; Gary J Nabel; Hanneke Schuitemaker; Lynn Morris; Barton F Haynes; John R Mascola
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

View more
  67 in total

1.  Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.

Authors:  Lindsay K Nicholson; Harsh Pratap; Elisabeth Bowers; Elise Gunzburger; Srinivasa R Bandi; Edward M Gardner; Brent E Palmer; Timothy Wright; John Kittelson; Edward N Janoff
Journal:  Immunobiology       Date:  2018-09-07       Impact factor: 3.144

Review 2.  Atypical memory B cells in human chronic infectious diseases: An interim report.

Authors:  Silvia Portugal; Nyamekye Obeng-Adjei; Susan Moir; Peter D Crompton; Susan K Pierce
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

3.  T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.

Authors:  James J Knox; Marcus Buggert; Lela Kardava; Kelly E Seaton; Michael A Eller; David H Canaday; Merlin L Robb; Mario A Ostrowski; Steven G Deeks; Mark K Slifka; Georgia D Tomaras; Susan Moir; M Anthony Moody; Michael R Betts
Journal:  JCI Insight       Date:  2017-04-20

4.  Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Authors:  James W Austin; Clarisa M Buckner; Lela Kardava; Wei Wang; Xiaozhen Zhang; Valerie A Melson; Ryan G Swanson; Andrew J Martins; Julian Q Zhou; Kenneth B Hoehn; J Nicholas Fisk; Yiannis Dimopoulos; Alexander Chassiakos; Sijy O'Dell; Margery G Smelkinson; Catherine A Seamon; Richard W Kwan; Michael C Sneller; Stefania Pittaluga; Nicole A Doria-Rose; Adrian McDermott; Yuxing Li; Tae-Wook Chun; Steven H Kleinstein; John S Tsang; Constantinos Petrovas; Susan Moir
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

5.  Maturational characteristics of HIV-specific antibodies in viremic individuals.

Authors:  Eric Meffre; Aaron Louie; Jason Bannock; Leo J Y Kim; Jason Ho; Cody C Frear; Lela Kardava; Wei Wang; Clarisa M Buckner; Yimeng Wang; Olivia R Fankuchen; Kathleen R Gittens; Tae-Wook Chun; Yuxing Li; Anthony S Fauci; Susan Moir
Journal:  JCI Insight       Date:  2016-03-17

6.  Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals.

Authors:  Jairo M Montezuma-Rusca; Susan Moir; Lela Kardava; Clarisa M Buckner; Aaron Louie; Leo J Y Kim; Brian H Santich; Wei Wang; Olivia R Fankuchen; Gabriella Diaz; Janine R Daub; Sergio D Rosenzweig; Tae-Wook Chun; Yuxing Li; Raul C Braylan; Katherine R Calvo; Anthony S Fauci
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

7.  Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation.

Authors:  Denise Lau; Linda Yu-Ling Lan; Sarah F Andrews; Carole Henry; Karla Thatcher Rojas; Karlynn E Neu; Min Huang; Yunping Huang; Brandon DeKosky; Anna-Karin E Palm; Gregory C Ippolito; George Georgiou; Patrick C Wilson
Journal:  Sci Immunol       Date:  2017-01-27

8.  The Regulation of Inherently Autoreactive VH4-34-Expressing B Cells in Individuals Living in a Malaria-Endemic Area of West Africa.

Authors:  Geoffrey T Hart; Munir Akkaya; Asiya S Chida; Chungwen Wei; Scott A Jenks; Christopher Tipton; Chenfeng He; Ben S Wendel; Jeff Skinner; Gunjan Arora; Kassoum Kayentao; Aissata Ongoiba; Ogobara Doumbo; Boubacar Traore; David L Narum; Ning Jiang; Peter D Crompton; Ignacio Sanz; Susan K Pierce
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

9.  OMIP-068: High-Dimensional Characterization of Global and Antigen-Specific B Cells in Chronic Infection.

Authors:  Katherine Cascino; Mario Roederer; Thomas Liechti
Journal:  Cytometry A       Date:  2020-08-28       Impact factor: 4.355

10.  Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens.

Authors:  Clarisa M Buckner; Lela Kardava; Xiaozhen Zhang; Kathleen Gittens; J Shawn Justement; Colin Kovacs; Adrian B McDermott; Yuxing Li; Mohammad M Sajadi; Tae-Wook Chun; Anthony S Fauci; Susan Moir
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.